Alexandre Zanghellini (@biopraxis) 's Twitter Profile
Alexandre Zanghellini

@biopraxis

Protein designer, synthetic biologist, entrepreneur (@ArzedaCo). Part-time scuba diver, and currently working on my horsemanship! Views are my own.

ID: 1036395709

calendar_today26-12-2012 05:31:01

167 Tweet

322 Followers

87 Following

Arzeda (@arzedaco) 's Twitter Profile Photo

Arzeda is partnering with AAK to accelerate the innovation of plant-based oils across the food industry. With our #AI-based #enzyme design technology, we're working to create a sustainable solution to #edibleoil. Read more: prn.to/3MN2ONZ #proteindesign #machinelearning

Arzeda (@arzedaco) 's Twitter Profile Photo

Our CEO Alexandre Zanghellini recently spoke with FoodNavigator.com's Katy Askew on how Arzeda and AAK are partnering to produce plant-based #edibleoils more sustainably and efficiently through the power of #AI, meeting the growing demand for healthy foods: bit.ly/3TXezUw

Cedric🧬➰🧬Feschotte (@cedricfeschotte) 's Twitter Profile Photo

💥Our new paper just out Science Magazine! Antiviral activity of a human protein of retroviral origin A study led fearlessly by John Frank We propose that the human genome encodes a deep pool of antiviral proteins derived from retroviruses! science.org/doi/10.1126/sc…

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

It was a pleasure being back in San Franscico at ABLC Next 2022 and see so many familiar faces. Can't wait to attend next year.

Steven Pinker (@sapinker) 's Twitter Profile Photo

Trust in legitimate truth-seeking institutions (science, academia, journalism, publishers, govt record-keeping agencies) is the only cure for public irrationality, which means those institutions must constantly earn & renew it.

Arzeda (@arzedaco) 's Twitter Profile Photo

Hear from Arzeda on our latest innovation, Bio-FDCA, at the 4th International Conference on #Biopolymers and #Bioplastics in Rome on 11/14! Learn how we're creating a greener, cost-effective alternative to PET through our AI-designed #enzymes. Learn more: bit.ly/3tnBZqQ

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Excited to see @Open_Fold getting more traction. This is important for the field of AI in protein science. Arzeda is now in even better company.

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Indeed Itai Yanai. I guess I would say the scientific method is the process to validate insights/results a posteriori that were intuited and obtained otherwise.

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

The Liz Kellogg ❄️🔬 lab did it again!!! This time they report in Nature the first full structure of the shCAST CRISPR-associated transposome. Very proud of Liz Kellogg ❄️🔬 and fascinating to understand how these fantastic nanomachines work!

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

So excited by our first foray in pharma, accelerating the development of the next generation protein biologics drug to improve patient outcomes.

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

I am so amazingly proud of my wife Liz Kellogg ❄️🔬 , my partner in life and science! It's an inspiration to see her group pushing the envelope in gene editing with her unique interdisciplinary approach combining cryo-EM, biochemistry and protein design. Way to go, Liz Kellogg ❄️🔬!

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

This is a huge validation of the importance of protein design. Arzeda cofounder David Baker is a gratifying choice. This signals the arrival of protein design as a fundamental tool in chemistry. I spent my PhD working on enzyme design.. and look where we are now!

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Feels like we summited Mount Everest, celebrating David Baker's Nobel Prize. De novo enzyme design was thought to be impossible by many... look where we are now! Honored to be invited to this celebration, to share my expertise, and reunite with friends. Onward & upward! Arzeda

Feels like we summited Mount Everest, celebrating David Baker's Nobel Prize. De novo enzyme design was thought to be impossible by many... look where we are now! Honored to be invited to this celebration, to share my expertise, and reunite with friends. Onward &amp; upward! <a href="/ArzedaCo/">Arzeda</a>
Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Efficient AI models that can rapidly learn from high quality but limited datasets is critical for practical protein design. Plus Arzeda integrates to commercial scale mfg, so be prepared for some magic! Thx DARPA for working with us on this! #ai #proteindesign

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Excited to announce that not only we have commercialized one of the first protein design consumer product, but that we have now successfully expanded production on multiple continents to meet growing demand. Thanks to the Arzeda team - you worked relentlessly to get there!

Alexandre Zanghellini (@biopraxis) 's Twitter Profile Photo

Super excited to be at SynBioBeta this year (just landed in San Jose!). Thanks John Cumbers. Let's talk protein design, performance consumer products and sustainability. And I can't wait to get a pulse on the latest in the #synbio community. #proteindesign #ai